SYK and ischemic stroke: In experimental ischemic stroke, TREM-1 acts by activating the pro-inflammatory pathways NF-κB and inflammasome (NLRP3)/caspase-1, which occurs through interacting with spleen tyrosine kinase (SYK) [61].